On December 15, 2024, Pharming Technologies B.V. ("Pharming”), a wholly-owned subsidiary of Pharming Group N.V., announced a ...

Stice to transition from role as Chief Executive Officer; Kaes Van't Hof, current President, will assume Chief Executive Officer role; Austen Gilfillian, current Vice Pr ...

Leiden, the Netherlands, February 10, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) ...

Global markets have recently experienced significant volatility, with U.S. stocks mostly lower due to AI competition fears and ongoing tariff risks, while European equities were buoyed by strong ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

ALX On­col­o­gy is forg­ing ahead with a treat­ment ap­proach that has long been aban­doned by oth­er drug­mak­ers, eye­ing a po­ten­tial ac­cel­er­at­ed ap­proval path­way for ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...

Leiden, the Netherlands, January 21, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces it will hold an Extraordinary General ...